Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixabepilone in Platinum-Pretreated NSCLC
NCT00035516Phase 2Completed
- Sponsor
- R-Pharm
- Start
- Feb 2001
- Primary completion
- Apr 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ixabepilone in non-small cell lung cancer (NSCLC), sponsored by R-Pharm. Primary endpoint: Objective Response Rate. Started Feb 2001; status: completed.
02
Drugs
ixabepilone
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00035516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00035516.